Cell & Gene
ACROBiosystems Launches Initiative to Boost Ex Vivo Cell Manufacturing Support
ACROBiosystems, one of the leading providers of innovative tools and solutions used from discovery to the clinic, has announced a new corporate initiative ...
March 05, 2024 | News
CARsgen Therapeutics Receives NMPA Approval for Breakthrough Multiple Myeloma CAR T-Cell Therapy
CARsgen Therapeutics, a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that t...
March 04, 2024 | News
Andelyn Biosciences Selected for FNIH Gene Therapy Programs
Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been sele...
February 29, 2024 | News
Immunofoco Achieves Historic Dual IND Approval for Groundbreaking EpCAM CAR-T Therapy
EpCAM, known for its presence in circulating tumor cells (CTCs) and high expression in primary and metastatic lesions of gastrointestinal tumors, r...
February 26, 2024 | News
WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced that the U.S. Food and Dr...
February 21, 2024 | News
Neurophth Completes Enrollment for Opvika® LHON Gene Therapy Trial in the U.S.
Neurophth Therapeutics, Inc. ("Neurophth"), a pioneer in gene therapies, today announced the successful completion of patient enrollment for its Phase I/II...
February 20, 2024 | News
Melanoma Research Alliance Applauds FDA Approval of First Cellular Therapy in Melanoma
AMTAGVI marks the first individualized Tumor Infiltrating Lymphocyte (TIL) therapy to receive FDA approval for any cancer. In this innovative thera...
February 17, 2024 | News
FDA Prioritizes Review of Bristol Myers Squibb's Augtyro™ for NTRK-Positive Solid Tumors
Bristol Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for A...
February 15, 2024 | News
Atara Biotherapeutics Submits Investigational New Drug Application for ATA3219 to Treat Lupus Nephritis
Lupus nephritis, a condition affecting the kidneys, presents a challenging treatment landscape with limited efficacy from existing therapies. ATA32...
February 15, 2024 | News
Multiply Labs, Thermo Fisher Expand Partnership for Cell Therapy Automation
Through integration with Multiply Labs' robotic technology, Thermo Fisher Scientific’s advanced, industry-leading cell therapy instruments, including...
February 13, 2024 | News
BioNTech's $200 Million Investment in Autolus Marks Milestone in Strategic CAR-T Collaboration, Revolutionizing Cancer Therapy
Strategic alliance leverages manufacturing and commercial infrastructure as well as technology with the aim to advance both...
February 08, 2024 | News
AstraZeneca Boosts US Manufacturing to Accelerate Cell Therapy Advancements
AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in the US for critic...
February 07, 2024 | News
Acepodia Gains FDA Clearance for ACE2016, Initiates Phase 1 Study on Solid Tumor Treatment
This clearance marks a significant milestone for Acepodia, allowing the initiation of a Phase 1, first-in-human clinical trial to assess th...
February 05, 2024 | News
Sirius Therapeutics Begins Phase 1 Trial for Long-Acting Factor XI siRNA Anticoagulant
"This study is based on in vivo studies that have demonstrated a nearly 100% reduction in FXI levels for up to 6 months without bleeding events a...
February 04, 2024 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
